With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Transforming the landscape of drug discovery with next-gen capabilities in obesity research, small molecule and antibody design, antibody-drug conjugate development, and interactive AI AlpaMeld Logo ...

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a ...

Celltrion targets innovative drug development with new ADC and antibody candidates Celltrion aims for growth by venturing ...

AbbVie and Simcere Zaiming have announced an option-to-license agreement for the development of an investigational drug candidate, SIM0500.

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...

NEW HAVEN, Conn. and UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Biohaven Ltd. (NYSE: BHVN) and Merus N.V.

Agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform.

To learn more about how the Rapid Bispecific Antibody Discovery process can align with your therapeutic development needs, please contact Invenra.

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.